International Affiliates- SEWON CELLONTECH is a bio-engineering company based in Seoul, Korea. The company was established in 1971. Tissue Engineering Research group was founded in 1996.
- SEWON CELLONTECH provides various bio-medical therapeutics based on cellular and tissue engineering technologies as a key player in the bio-medical field.
- SEWON CELLONTECH is publicly listed in Korean stock market (KOSPI 200) since 1997 and employs in excess of 550 people in Korea, U.K., China and USA.
- SEWON CELLONTECH currently accelerates to market regenerative medicine therapies of cartilage, bone, skin, fat and UCB stem cells with innovative RMS - "Regenerative Medical System" to hospitals or laboratories where advanced regenerative therapeutics is needed.
- SEWON CELLONTECH currently accelerates to market regenerative medicine therapies of cartilage, bone, skin, fat and UCB stem cells with innovative RMS - "Regenerative Medical System" to hospitals or laboratories where advanced regenerative therapeutics is needed.
- Worldwide it has partners in with over seven countries including India to propagate its international, collagen based CE certified adult stem cell based biotechnology.
- Over the last 12 years, medical doctors who are their clinical partners have treated more than 2,000 arthritic patients with cartilage RMP and more than 200 patients with bone RMP.
- Up to now, the company has listed five kinds of medical practices: Cartilage RMP, Bone RMP, Fat RMP, Skin RMP and Cord Blood Cell Banking RMP.
- SEWON CELLONTECH started cord blood banking services in 2001, and is currently the largest cord blood bank of South Korea with over 20,000 cord blood units stored.
Certain Highlights:
1997
Approved CHONDRONT as the first bio-pharmaceutical product by KFDA Listed on Korean Stock Exchange (KOSPI 200) - Till date the only listed cell therapeutics company in Korea
2001
Approved KGMP (Korean Good Manufacturing Practices) for Cell Hospital Manufacturing Facility by KFDA - first company in Korea to get KGMP for Cell Therapeutics
2003
Accredited ISO 9001/2000 for Cell Bank facilities and Baby Cell 5C program Designated 'World Class Product'- OSSRON by Ministry of Commerce, Industry and Energy
2005
Awarded "Jang Young Sil IR 52"- CHONDRONT By Korea Industrial Technology Association. Acquired 'KT (Excellent Korean Technology) Mark'- CHONDRONT by Ministry of Science of Technology
2006
Accredited ISO 13485/ CE Marked for RMS (Regenerative Medical System) Patent registered for the Adipose Tissue Regenerative System- ADIFORMT
Launched "Atelocollagen Cosmeceutical Product" NOVOSTRATAT
Launched "Atelocollagen Cosmeceutical Product" NOVOSTRATAT
